Increased stimulatory capacity of antigen presenting cells at the site of autoimmune inflammation interferes with regulatory T cell function by Van Wijk, Femke et al.
POSTER PRESENTATION Open Access
Increased stimulatory capacity of antigen presenting
cells at the site of autoimmune inflammation
interferes with regulatory T cell function
Femke Van Wijk, E Wehrens
*, C Duurland, B Vastert, M Klein, J Meerding, W De Jager, B Prakken
From 18th Pediatric Rheumatology European Society (PReS) Congress
Bruges, Belgium. 14-18 September 2011
Background
FOXP3+ regulatory T cells (Treg) are critical in main-
taining self tolerance and are therefore considered impor-
tant targets for the treatment of autoimmune disease.
However, environmental factors at the site of autoim-
mune inflammation, such as enhanced costimulatory
potential of antigen presenting cells (APC) and increased
proinflammatory cytokine production, can negatively
affect Treg function, thereby limiting effectiveness of
these Treg targeted approaches.
Aim
Here we studied the phenotype of APC present at the
site of inflammation in patients with Juvenile Idiopathic
Arthritis (JIA) and investigated whether these cells can
interfere with Treg mediated suppression.
Methods
Mononuclear cells were isolated from peripheral blood
(PB) of healthy controls (HC) and from paired PB and
synovial fluid (SF) of JIA patients. The phenotype of
APC was analysed using flow cytometry. In vitro sup-
pression assays were performed to study T cell activa-
tion and Treg mediated suppression in the presence of
SF and PB derived APC.
Results
Monocytes from the site of inflammation displayed a
more pro-inflammatory phenotype, with significantly
increased costimulatory molecule expression, compared
to monocytes from PB. In line with this pro-inflamma-
tory phenotype, SF APC induced enhanced proliferation
of effector cells and decreased suppression of effector
cell proliferation in the presence of Treg.
Conclusions
APC from the site of inflammation have an enhanced sti-
mulatory capacity that interferes with Treg mediated
suppression. Therefore, this increased stimulatory poten-
tial should be targeted as well, in order for a Treg enhan-
cing approach to be fully effective in the treatment of
autoimmune inflammation.
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